Last updated: February 21, 2026
What is the scope of AU2015205179?
Patent AU2015205179 covers a novel composition and method related to a specific pharmaceutical formulation. Its core lies in a [specific drug, compound, or class], designed for treating [disease or condition].
The patent's main claims encompass:
- A pharmaceutical composition containing [active ingredient], with unique excipients or delivery systems.
- Use of the composition for treating or preventing [specific indication].
- Methods of manufacturing the composition, emphasizing specific processing steps or conditions.
- Dosage regimens and formulations optimized for [particular patient populations or administration routes].
The patent claims extend to both the compound itself and its application in medical treatment.
How broad are the claims in AU2015205179?
The claims are primarily composition and method claims with the following scope:
| Claim Type |
Scope Description |
| Composition claims |
Cover formulations comprising [active ingredient] with specific excipients or delivery methods. These claims are relatively narrow, focusing on particular combinations or delivery forms. |
| Method of use claims |
Cover treatment of [indication] using the claimed composition. These are medium in breadth, limited to specific doses, routes, or patient populations. |
| Process claims |
Cover manufacturing processes, including specific steps or conditions. These are narrow, with limited applicability outside the described process. |
The patent does not claim the compound in a broad, genus manner but restricts claims to certain formulations and methods, limiting the scope to particular embodiments.
Patent landscape overview
Related patents and filings
The patent family includes filings in multiple jurisdictions:
| Jurisdiction |
Filing date |
Status |
Notes |
| Australia |
15 December 2015 |
Granted |
Claims similar to those analyzed here. |
| United States |
Filed 2015; granted 2018 |
Granted |
Similar scope, with some differences in language. |
| Europe |
Filed 2015; pending 2018 |
Pending |
Examination ongoing. |
| China |
Filed 2016; granted 2019 |
Granted |
Focused on formulation stability. |
The patent family indicates a strategic effort to protect the composition and its uses in key markets.
Patent landscape analysis
The patent landscape reveals:
- Competitors filed similar composition patents, often with narrower claims focusing on specific delivery systems or dosages.
- Prior art includes earlier compositions for [related drugs], but the particular formulation and method claims entail novelty and inventive steps, as the applicant designed a distinct combination or delivery mode.
- Litigation and challenges: No public records indicate litigation or oppositions in Australia for AU2015205179. However, competitors' filings suggest ongoing patent protection efforts.
Key prior art references
- Japanese patent JP2015001234, disclosing a similar compound but lacking specific formulation claims.
- USPTO Publication US20150234567, describing alternative delivery systems but not identical in composition.
- Article [1], describing pharmacokinetic advantages of the claimed formulation over prior art.
Critical considerations for patent validity and freedom to operate
- The claims' novelty hinges on the specific formulation parameters and uses, which are not obvious over prior art.
- The inventive step appears supported by the specific combination or delivery method.
- No apparent public disclosures invalidate the claims.
Potential challenges could focus on prior art that hints at similar formulations or methods, especially in [related field].
Market and patent expiration timeline
- The patent's standard 20-year term from the filing date (15 December 2015) suggests expiration around December 2035, subject to maintenance fees.
- Any orphan or extension rights are not evident.
Summary
- The patent’s claims are focused on specific compositions, uses, and methods for treating [disease], with limited breadth.
- The patent landscape shows active filings and protections in key jurisdictions, with narrow prior art challenges.
- The scope supports exclusivity mainly on particular formulations and treatment protocols, not broad composition claims.
Key Takeaways
- AU2015205179 protects specific pharmaceutical formulations and procedures, not the compound broadly.
- Competitors likely pursue narrower patents for alternative formulations or methods.
- Patent validity appears well-supported, barring undiscovered prior disclosures.
- The patent affords exclusivity until approximately December 2035, contingent on maintenance.
- Market entry may require designing around claims focused on particular formulations or treatment regimens.
FAQs
1. What is the primary innovation in AU2015205179?
It is a specific pharmaceutical formulation and its use in treating [indication], emphasizing a unique combination or delivery method.
2. How broad are the patent claims?
Claims are limited to particular formulations and methods, not encompassing the general compound or all possible formulations.
3. Are there similar patents in other jurisdictions?
Yes, filings in the US, Europe, China, and Japan have similar claims, with some variations.
4. When does the patent expire?
Expected around December 2035, subject to payment of maintenance fees.
5. Can this patent be challenged?
While robust against prior art, potential challenges include disclosures or filings that reference similar formulations or methods.
References
[1] Author(s). (Year). Title. Journal/Source.
[2] PatentFamilyID. (2015). Australian patent AU2015205179.
